v3-substanceAdminSubstitution
type: CodeSystem
node role: treeRoot
id:
  v: v3-substanceAdminSubstitution
language:
  v: en
text:
  status:
    v: generated
  div:
    v: Generated Narrative: CodeSystem v3-substanceAdminSubstitution Language: en Properties This code system defines the following properties for its concepts Name Code URI Type Description Not Selectable notSelectable http://hl7.org/fhir/concept-properties#notSelectable boolean Indicates that the code is abstract - only intended to be used as a selector for other concepts Status status http://hl7.org/fhir/concept-properties#status code Designation of a concept's state. Normally is not populated unless the state is retired. Concepts This case-sensitive code system http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution defines the following codes in a Is-A hierarchy: Lvl Code Display Definition Not Selectable Status 1 _ActSubstanceAdminSubstitutionCode ActSubstanceAdminSubstitutionCode Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects. true active 2 E equivalent Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product. active 3 EC equivalent composition Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril active 4 BC brand composition Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven active 4 G generic composition Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp) active 3 TE therapeutic alternative Substitution occurred or is permitted with another produ…
url:
  v: http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution
identifier:
  system:
    v: urn:ietf:rfc:3986
  value:
    v: urn:oid:2.16.840.1.113883.5.1070
version:
  v: 4.0.0
name:
  v: SubstanceAdminSubstitution
title:
  v: Substance Admin Substitution
status:
  v: active
experimental:
  v: false
date:
  v: 2019-03-20
publisher:
  v: Health Level Seven International
contact:
  telecom:
    system:
      v: url
    value:
      v: http://hl7.org
  telecom:
    system:
      v: email
description:
  v: Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.
copyright:
  v: This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html
case sensitive:
  v: true
hierarchy meaning:
  v: is-a
content:
  v: complete
property:
  code:
    v: notSelectable
  uri:
    v: http://hl7.org/fhir/concept-properties#notSelectable
  description:
    v: Indicates that the code is abstract - only intended to be used as a selector for other concepts
  type:
    v: boolean
property:
  code:
    v: status
  uri:
    v: http://hl7.org/fhir/concept-properties#status
  description:
    v: Designation of a concept's state. Normally is not populated unless the state is retired.
  type:
    v: code
concept:
  code:
    v: _ActSubstanceAdminSubstitutionCode
  display:
    v: ActSubstanceAdminSubstitutionCode
  definition:
    v: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.
  property:
    code:
      v: notSelectable
    value: boolean
      v: true
  property:
    code:
      v: status
    value: code
      v: active
  concept:
    code:
      v: E
    display:
      v: equivalent
    definition:
      v: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
    property:
      code:
        v: status
      value: code
        v: active
    property:
      code:
        v: internalId
      value: code
        v: 23107
    concept:
      code:
        v: EC
      display:
        v: equivalent composition
      definition:
        v: Substitution occurred or is permitted with another product that is a: * pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester * pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration *Examples:* * *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate * *Pharmaceutical equivalent:* Lisonpril for Zestril
      property:
        value: code
      property:
        value: code
    concept:
      code:
        v: TE
      display:
        v: therapeutic alternative
      definition:
        v: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. *Examples:* * ranitidine for Tagamet
      property:
        value: code
      property:
        value: code
  concept:
    code:
      v: F
    display:
      v: formulary
    definition:
      v: This substitution was performed or is permitted based on formulary guidelines.
    property:
      code:
        v: status
      value: code
        v: active
    property:
      code:
        v: internalId
      value: code
        v: 16625
  concept:
    code:
      v: N
    display:
      v: none
    definition:
      v: No substitution occurred or is permitted.
    property:
      code:
        v: status
      value: code
        v: active
    property:
      code:
        v: internalId
      value: code
        v: 16622

v: status

code
v: active

v: internalId

code
v: 23108

v: BC

v: brand composition

v: Substitution occurred or is permitted between equivalent Brands but not Generics *Examples:* * Zestril for Prinivil * Coumadin for Jantoven

code:
  v: status
value: code
  v: active

code:
  v: internalId
value: code
  v: 23109

v: G

v: generic composition

v: Substitution occurred or is permitted between equivalent Generics but not Brands *Examples:* * Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)

code:
  v: status
value: code
  v: active

code:
  v: internalId
value: code
  v: 16623

v: status

code
v: active

v: internalId

code
v: 16624

v: TB

v: therapeutic brand

v: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > *Examples:* * Zantac for Tagamet

code:
  v: status
value: code
  v: active

code:
  v: internalId
value: code
  v: 23105

v: TG

v: therapeutic generic

v: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > *Examples:* * Ranitidine for cimetidine

code:
  v: status
value: code
  v: active

code:
  v: internalId
value: code
  v: 23106